EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The wound microbiome in chronic wounds: a biomarker and therapeutic target

Bartosz Molasy, Małgorzata Wrzosek

Journal of Applied Microbiology · 02.02.2026 · 137 (2)

DOI: 10.1093/jambio/lxag025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Applied Microbiology, online erschienen am 28.01.2026. Verfasst von Bartosz Molasy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Medicine, Collegium Medicum, Jan Kochanowski University of Kielce, 25-369 Kielce, Poland. Hauptthemen laut MEDLINE: Microbiota, Wounds and Injuries, Wound Infection. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland, Medical University of Warsaw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, remain a major global healthcare challenge, associated with substantial morbidity, risk of limb loss, and high healthcare costs. Increasing evidence indicates that the wound microbiome modulates inflammation, tissue repair, and responses to therapy, thereby influencing clinical outcomes. This review summarizes current knowledge on the composition and function of chronic wound microbial communities and discusses their clinical relevance as prognostic biomarkers and therapeutic targets. Microbiome structure is shaped by wound etiology, chronicity, anatomical site, and host comorbidities. Dysbiosis and biofilm formation contribute to persistent inflammation, antimicrobial tolerance, and delayed healing. Advances in sequencing and multi-omics technologies have improved microbial characterization and enabled the identification of candidate microbial signatures associated with healing trajectories. Emerging microbiome-modulating strategies such as probiotics, bacteriophages, topical oxygen approaches, and nanotechnology-based interventions show potential to shift wound ecosystems toward a pro-healing state; however, robust clinical validation remains limited. Further clinical studies are needed to validate microbiome-guided diagnostics and interventions and to establish standardized protocols for their application in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaWounds and InjuriesWound InfectionHumansWound HealingBiomarkersChronic DiseaseBiofilmsProbiotics

Stichwörter der Autor:innen

antimicrobial resistancebacteriophagesbiofilmchronic wound infectionsprobioticswound microbiome

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Surgical Medicine, Collegium Medicum, Jan Kochanowski University of Kielce, 25-369 Kielce, Poland.
  • Department of General Surgery, St Alexander Hospital, 25-316 Kielce, Poland.
  • Department of Biochemistry and Pharmacogenomics, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Pharmaceutical Sciences, Collegium Medicum, Jan Kochanowski University of Kielce, 25-369 Kielce, Poland.

Förderung

  • National Science Centre, Poland
  • Medical University of Warsaw

Zitieren

APA

Molasy, B., & Wrzosek, M. (2026). The wound microbiome in chronic wounds: a biomarker and therapeutic target. Journal of Applied Microbiology, 137(2). https://doi.org/10.1093/jambio/lxag025

Vancouver

Molasy B, Wrzosek M. The wound microbiome in chronic wounds: a biomarker and therapeutic target. Journal of Applied Microbiology. 2026;137(2). doi:10.1093/jambio/lxag025

BibTeX
@article{Molasy2026,
  author = {Molasy, Bartosz and Wrzosek, Małgorzata},
  title = {The wound microbiome in chronic wounds: a biomarker and therapeutic target},
  journal = {Journal of Applied Microbiology},
  year = {2026},
  volume = {137},
  number = {2},
  doi = {10.1093/jambio/lxag025}
}
Kostenlos starten →